salvage therapies superior to chemotherapy in post-transplant r/r chl
Published 2 years ago • 294 plays • Length 2:10Download video MP4
Download video MP3
Similar videos
-
2:46
update of the admiral trial: gilteritinib vs salvage chemotherapy prior to hsct in flt-3 mutated aml
-
2:42
the current role of chemotherapy in the treatment of hodgkin lymphoma & the impact of novel agents
-
2:15
hovon/llpc transplant brave: novel salvage chemotherapy for r/r hodgkin lymphoma
-
2:13
reinforcing transplantation with consolidation therapy in hodgkin lymphoma
-
1:58
incorporating immunotherapy in the frontline & salvage treatment of hodgkin lymphoma
-
1:45
ham-ven as salvage treatment for r/r aml: results from the sal-relax trial
-
1:36
the changing role of chemotherapy in lymphoma and the value of novel immunotherapies
-
1:59
the efficacy of venetoclax-based salvage therapy in patients with previously treated r/r aml
-
1:37
a prospective trial of radiation-free chemotherapy in high- and low-risk hl
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
2:16
venetoclax-based salvage therapy in patients with r/r aml previously treated with targeted agents
-
2:34
new salvage treatment for aml/mds after allogeneic transplant: the viola trial
-
1:00
the role of non-covalent btk inhibitors in the treatment of non-hodgkin lymphoma
-
6:16
overview of novel restore and target treatment approach to classical hodgkin lymphoma
-
1:18
chemotherapy as a pre-treatment to subvert ici resistance in sts
-
5:21
chemo-free regimens in lymphoma
-
1:43
maintenance nivolumab in post-stem cell transplant hodgkin lymphoma
-
0:53
go-flag: bridge therapy to allo-sct in r/r aml